Publishing research using ab5089? Please let us know so that we can cite the reference in this datasheet.

ab5089 has been referenced in 28 publications.

  • Fiorito E  et al. CTCF modulates Estrogen Receptor function through specific chromatin and nuclear matrix interactions. Nucleic Acids Res 44:10588-10602 (2016). ChIP ; Human . PubMed: 27638884
  • Jozwik KM  et al. FOXA1 Directs H3K4 Monomethylation at Enhancers via Recruitment of the Methyltransferase MLL3. Cell Rep 17:2715-2723 (2016). CHIPseq ; Human . PubMed: 27926873
  • Griffon A  et al. Integrative analysis of public ChIP-seq experiments reveals a complex multi-cell regulatory landscape. Nucleic Acids Res 43:e27 (2015). PubMed: 25477382
  • Sasahara M  et al. Overexpression of androgen receptor and forkhead-box A1 protein in apocrine breast carcinoma. Anticancer Res 34:1261-7 (2014). Human . PubMed: 24596370
  • Caizzi L  et al. Genome-wide activity of unliganded estrogen receptor-a in breast cancer cells. Proc Natl Acad Sci U S A 111:4892-7 (2014). ChIP, WB ; Human . PubMed: 24639548
  • Gosalia N  et al. Architectural proteins CTCF and cohesin have distinct roles in modulating the higher order structure and expression of the CFTR locus. Nucleic Acids Res 42:9612-22 (2014). ChIP ; Human . PubMed: 25081205
  • Ballester B  et al. Multi-species, multi-transcription factor binding highlights conserved control of tissue-specific biological pathways. Elife 3:e02626 (2014). CHIPseq . PubMed: 25279814
  • Dryden NH  et al. Unbiased analysis of potential targets of breast cancer susceptibility loci by Capture Hi-C. Genome Res 24:1854-68 (2014). ChIP . PubMed: 25122612
  • He B  et al. GATA2 facilitates steroid receptor coactivator recruitment to the androgen receptor complex. Proc Natl Acad Sci U S A 111:18261-6 (2014). PubMed: 25489091
  • Caravaca JM  et al. Bookmarking by specific and nonspecific binding of FoxA1 pioneer factor to mitotic chromosomes. Genes Dev 27:251-60 (2013). ICC/IF ; Human . PubMed: 23355396
  • Meyer KB  et al. Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. Am J Hum Genet 93:1046-60 (2013). PubMed: 24290378
  • Robinson JL  et al. Elevated levels of FOXA1 facilitate androgen receptor chromatin binding resulting in a CRPC-like phenotype. Oncogene N/A:N/A (2013). Human . PubMed: 24292680
  • Holmes KA  et al. Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells. Proc Natl Acad Sci U S A 109:2748-53 (2012). ChIP ; Human . PubMed: 21536917
  • Clarke CL & Graham JD Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes. PLoS One 7:e35859 (2012). WB . PubMed: 22545144
  • Hurtado A  et al. FOXA1 is a key determinant of estrogen receptor function and endocrine response. Nat Genet 43:27-33 (2011). ChIP ; Human . PubMed: 21151129
  • Sérandour AA  et al. Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers. Genome Res 21:555-65 (2011). ChIP ; Human . PubMed: 21233399
  • Panov AV  et al. Metabolic and functional differences between brain and spinal cord mitochondria underlie different predisposition to pathology. Am J Physiol Regul Integr Comp Physiol 300:R844-54 (2011). PubMed: 21248309
  • McMullin RP  et al. A FOXA1-binding enhancer regulates Hoxb13 expression in the prostate gland. Proc Natl Acad Sci U S A 107:98-103 (2010). IHC-P, ChIP ; Mouse . PubMed: 20018680
  • Bernardo GM  et al. FOXA1 is an essential determinant of ERalpha expression and mammary ductal morphogenesis. Development 137:2045-54 (2010). ChIP ; Human . PubMed: 20501593
  • Taube JH  et al. Foxa1 functions as a pioneer transcription factor at transposable elements to activate Afp during differentiation of embryonic stem cells. J Biol Chem 285:16135-44 (2010). ChIP ; Mouse . PubMed: 20348100
  • Hua S  et al. Genomic antagonism between retinoic acid and estrogen signaling in breast cancer. Cell 137:1259-71 (2009). ChIP/Chip ; Human . PubMed: 19563758
  • Eeckhoute J  et al. Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers. Genome Res 19:372-80 (2009). ChIP ; Human . PubMed: 19129543
  • Nucera C  et al. FOXA1 is a potential oncogene in anaplastic thyroid carcinoma. Clin Cancer Res 15:3680-9 (2009). WB ; Human . PubMed: 19470727
  • Motallebipour M  et al. Differential binding and co-binding pattern of FOXA1 and FOXA3 and their relation to H3K4me3 in HepG2 cells revealed by ChIP-seq. Genome Biol 10:R129 (2009). ChIP, ChIP/Chip ; Human . PubMed: 19919681
  • Lupien M  et al. FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription. Cell 132:958-70 (2008). ChIP, ChIP/Chip ; Human . PubMed: 18358809
  • Eeckhoute J  et al. A cell-type-specific transcriptional network required for estrogen regulation of cyclin D1 and cell cycle progression in breast cancer. Genes Dev 20:2513-26 (2006). WB, ChIP ; Human . PubMed: 16980581
  • Carroll JS  et al. Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1. Cell 122:33-43 (2005). PubMed: 16009131
  • Nguyen TT  et al. Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene. Mol Cell Biol 25:2147-57 (2005). PubMed: 15743813


Sign up